Table III.
Survival status, n | ||||
---|---|---|---|---|
Clinicopathological parameters | N | Alive | Dead | P-value |
Gender | 0.406 | |||
Male | 72 | 40 | 32 | |
Female | 6 | 2 | 4 | |
Age, years | 0.813 | |||
<60 | 25 | 14 | 11 | |
≥60 | 53 | 28 | 25 | |
Tobacco smoking | 0.807 | |||
No | 23 | 13 | 10 | |
Yes | 55 | 29 | 26 | |
T classification | <0.010a | |||
T1-T2 | 47 | 33 | 14 | |
T3-T4 | 31 | 9 | 22 | |
Lymph node metastasis | 0.040a | |||
No | 43 | 28 | 15 | |
Yes | 35 | 14 | 21 | |
TNM clinical stage | <0.010a | |||
I–II | 27 | 23 | 4 | |
III–IV | 51 | 19 | 32 | |
Pathology grade | 0.107 | |||
Well/moderate | 47 | 29 | 18 | |
Poor/undifferentiated | 31 | 13 | 18 | |
Tumor location | ||||
Glottic | 47 | 25 | 22 | 0.762 |
Supraglottic | 24 | 14 | 10 | 0.762 |
Subglottic | 7 | 3 | 4 | 0.754 |
Ki-67 | <0.010a | |||
Low expression | 33 | 27 | 6 | |
High expression | 45 | 15 | 30 | |
ADAM10 | <0.010a | |||
Low expression | 29 | 27 | 2 | |
High expression | 49 | 15 | 34 |
Statistical analyses were performed by the Pearson χ2 test. ADAM, a disintegrin and metalloproteinase; TNM, tumor-node-metastasis.